Eledon Pharmaceuticals Stock Price on October 30, 2024
| ELDN Stock | USD 4.37 0.29 6.22% |
Below is the normalized historical share price chart for Eledon Pharmaceuticals extending back to September 17, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eledon Pharmaceuticals stands at 4.37, as last reported on the 2nd of December, with the highest price reaching 4.81 and the lowest price hitting 4.34 during the day.
If you're considering investing in Eledon Stock, it is important to understand the factors that can impact its price. Eledon Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Eledon Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.17, which denotes the company had a 0.17% return per unit of risk over the last 3 months. By reviewing Eledon Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.85% is justified by implied risk. Please utilize Eledon Pharmaceuticals' Mean Deviation of 3.62, downside deviation of 3.53, and Coefficient Of Variation of 565.26 to check if our risk estimates are consistent with your expectations.
As of the 2nd of December 2024, Common Stock Shares Outstanding is likely to grow to about 25.9 M, while Total Stockholder Equity is likely to drop about 60.7 M. . At this time, Eledon Pharmaceuticals' Price Book Value Ratio is very stable compared to the past year. As of the 2nd of December 2024, Price Earnings To Growth Ratio is likely to grow to 11.54, while Price To Sales Ratio is likely to drop 149.02. Eledon Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of September 2014 | 200 Day MA 2.6736 | 50 Day MA 3.5395 | Beta 0.766 |
Eledon |
Sharpe Ratio = 0.1704
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ELDN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.0 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.85 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Eledon Pharmaceuticals is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eledon Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 3.6602 | Book Value 1.847 | Enterprise Value 200.7 M | Enterprise Value Ebitda 0.8366 | Shares Float 46.3 M |
Related Headline
Lyra Therapeutics Headline on 30th of October 2024
Lyra Therapeutics, Inc. Short Interest Down 24.9 percent in ... by thelincolnianonline.com
Lyra Therapeutics, Inc. was the recipient of a large decrease in short interest during the month of October. As of October 15th, there was short interest totalling 2,140,000 shares, a decrease of 24.9 percent from the September 30th total of 2,850,000 shares. Based on an average daily volume of 993,700 shares,
Eledon Pharmaceuticals Valuation on October 30, 2024
It is possible to determine the worth of Eledon Pharmaceuticals on a given historical date. On October 30, 2024 Eledon was worth 3.6 at the beginning of the trading date compared to the closed value of 4.19. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eledon Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Eledon Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eledon Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eledon Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 3.78 | 4.12 | 3.54 | 3.59 | 9,913,075 | |
10/30/2024 | 3.60 | 4.41 | 3.50 | 4.19 | 3,162,836 |
| 4.07 | 4.76 | 3.95 | 4.65 | 1,002,401 |
| Backtest Eledon Pharmaceuticals | | | Eledon Pharmaceuticals History | | | Eledon Pharmaceuticals Valuation | Previous | Next |
Eledon Pharmaceuticals Trading Date Momentum on October 30, 2024
| On October 31 2024 Eledon Pharmaceuticals was traded for 4.65 at the closing time. The top price for the day was 4.76 and the lowest listed price was 3.95 . The trading volume for the day was 1 M. The trading history from October 31, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 10.98% . The overall trading delta against the current closing price is 17.66% . |
Eledon Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Eledon Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eledon Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eledon financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Eledon Pharmaceuticals Stock history
Eledon Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eledon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eledon Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eledon Pharmaceuticals stock prices may prove useful in developing a viable investing in Eledon Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 24.6 M | 25.9 M | |
| Net Loss | -31.1 M | -29.5 M |
Eledon Pharmaceuticals Quarterly Net Working Capital |
|
Eledon Pharmaceuticals Stock Technical Analysis
Eledon Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Eledon Pharmaceuticals Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Eledon Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Eledon Pharmaceuticals December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Eledon Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eledon Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eledon Pharmaceuticals stock market strength indicators, traders can identify Eledon Pharmaceuticals entry and exit signals to maximize returns
Eledon Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eledon Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eledon Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eledon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1437 | |||
| Jensen Alpha | 0.839 | |||
| Total Risk Alpha | 0.0386 | |||
| Sortino Ratio | 0.2051 | |||
| Treynor Ratio | 9.14 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eledon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.73 | Return On Assets (0.33) | Return On Equity (0.25) |
The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.